IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
p53 polymorphism and p21(WAF1/CIP1) haplotype in the intestinal gastric cancer and the precancerous lesions
Xi, YG1; Ding, KY1; Su, XL1; Chen, DF1; You, WC1; Shen, Y1; Ke, Y1
刊名CARCINOGENESIS
2004-11-01
DOI10.1093/carcin/bgh229
25期:11页:2201-2206
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
关键词[WOS]DEPENDENT KINASE INHIBITOR ; CODON 72 POLYMORPHISM ; LUNG-CANCER ; CERVICAL-CANCER ; BREAST-CANCER ; GENETIC SUSCEPTIBILITY ; WAF1/CIP1 GENE ; ARG ALLELE ; HIGH-RISK ; ASSOCIATION
英文摘要

The development of intestinal gastric carcinoma involves several precancerous stages. The environmental factor plays an important role in gastric carcinogenesis, while the host′s genetic makeup may influence the susceptibility to cancer. In this study we investigated correlations of the p53 variations at codon 72 and p21(WAF1/CIP1) haplotype with the risk of intestinal gastric carcinoma. Forty-eight intestinal gastric carcinoma cases (GC), 96 chronic atrophic gastritis (CAG), 96 intestinal metaplasia (IM) and 96 dysplasia (DYS) controls were enrolled in this study. The p53 codon 72 proline allele carriers were found to be more susceptible to progress to GC than to IM (OR = 2.22, 95%CI = 1.05-4.70, P = 0.038). Patients carrying homozygous p21(WAF1/CIP1) haplotype A, which contains the serine at codon 31, the cytidine at the 16th base of the second intron, and the cytidine at the 70th base of the exon 3 were more prone to develop GC than to reach the IM or DYS stage (IM versus GC, OR = 3.35, 95%CI = 1.11-10.15; DYS versus GC, OR = 3.27, 95%CI = 1.09-9.80, P = 0.035). The combination of p53 codon 72 variation with the p21(WAF1/CIP1) haplotype further distinguished the risk of GC from IM precancerous lesion (OR = 9.31, 95% CI = 1.77-48.85, P = 0.08). These results suggest that p53 and/or p21(WAF1/CIP1) genotype may influence the progression during gastric tumorigenesis.

语种英语
WOS记录号WOS:000225251200022
引用统计
被引频次:37[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/52768
专题北京大学临床肿瘤学院
作者单位1.Inner Mongolia Med Coll, Hohhot, Peoples R China
2.Chinese Natl Human Genome Ctr, Beijing, Peoples R China
3.Peking Univ, Sch Oncol, Beijing Inst Canc Res, Beijing, Peoples R China
4.Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China
5.Peking Union Med Coll, Beijing, Peoples R China
6.Peking Univ, Dept Cell Biol & Human Genet, Beijing 100871, Peoples R China
推荐引用方式
GB/T 7714
Xi, YG,Ding, KY,Su, XL,et al. p53 polymorphism and p21(WAF1/CIP1) haplotype in the intestinal gastric cancer and the precancerous lesions[J]. CARCINOGENESIS,2004,25(11):2201-2206.
APA Xi, YG.,Ding, KY.,Su, XL.,Chen, DF.,You, WC.,...&Ke, Y.(2004).p53 polymorphism and p21(WAF1/CIP1) haplotype in the intestinal gastric cancer and the precancerous lesions.CARCINOGENESIS,25(11),2201-2206.
MLA Xi, YG,et al."p53 polymorphism and p21(WAF1/CIP1) haplotype in the intestinal gastric cancer and the precancerous lesions".CARCINOGENESIS 25.11(2004):2201-2206.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Xi, YG]的文章
[Ding, KY]的文章
[Su, XL]的文章
百度学术
百度学术中相似的文章
[Xi, YG]的文章
[Ding, KY]的文章
[Su, XL]的文章
必应学术
必应学术中相似的文章
[Xi, YG]的文章
[Ding, KY]的文章
[Su, XL]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。